Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lemborexant: First Approval
Lesley J. Scott
Drugs (2020) Vol. 80, Iss. 4, pp. 425-432
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Priyadeep Bhutani, Gaurav Joshi, Nivethitha Raja, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2339-2381
Closed Access | Times Cited: 506
G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 419
New approaches to symptomatic treatments for Alzheimer’s disease
Jeffrey L. Cummings
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 161
Phenols in Pharmaceuticals: Analysis of a Recurring Motif
Kevin A. Scott, Philip B. Cox, Jón T. Njardarson
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7044-7072
Closed Access | Times Cited: 121
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis
Jing-Li Yue, Xiang-Wen Chang, Jun-Wei Zheng, et al.
Sleep Medicine Reviews (2023) Vol. 68, pp. 101746-101746
Closed Access | Times Cited: 49
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders
Clemens Muehlan, Cédric Vaillant, Isabelle Zenklusen, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 11, pp. 1063-1078
Closed Access | Times Cited: 70
The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis
Tao Xue, Xin Wu, Shujun Chen, et al.
Sleep Medicine Reviews (2021) Vol. 61, pp. 101573-101573
Closed Access | Times Cited: 68
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Cyclic tailor-made amino acids in the design of modern pharmaceuticals
Jiang Liu, Jianlin Han, Kunisuke Izawa, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112736-112736
Closed Access | Times Cited: 57
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
Russell Rosenberg, Leslie Citrome, Christopher L. Drake
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2549-2566
Open Access | Times Cited: 47
Emerging and upcoming therapies in insomnia
W.-H. Kim, Ho-Sook Kim
Translational and Clinical Pharmacology (2024) Vol. 32, Iss. 1, pp. 1-1
Open Access | Times Cited: 6
Structure-based development of a subtype-selective orexin 1 receptor antagonist
Jan Hellmann, Matthäus Drabek, Jie Yin, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 30, pp. 18059-18067
Open Access | Times Cited: 46
Synthetic Approaches to the New Drugs Approved during 2019
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 7, pp. 3604-3657
Closed Access | Times Cited: 36
Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway
Bruce Corser, Erica Eves, Jennifer Warren-McCormick, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 19, Iss. 6, pp. 1035-1042
Open Access | Times Cited: 13
Obstructive sleep apnea syndrome, orexin, and sleep–wake cycle: The link with the neurodegeneration
Mariana Fernandes, Claudio Liguori
Handbook of clinical neurology (2025), pp. 141-160
Closed Access
Pharmacological management of chronic insomnia disorder in Singapore: Recommendations from an expert panel
Roger Ho, Chau Sian Lim, Norman Sartorius, et al.
Proceedings of Singapore Healthcare (2025) Vol. 34
Open Access
Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Comparison of efficacy and safety of dual orexin receptor antagonists lemborexant and daridorexant for the treatment of insomnia: a systematic review and meta-analysis
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem
Mike Ufer, Debra Kelsh, Kerri A. Schoedel, et al.
SLEEP (2021) Vol. 45, Iss. 3
Open Access | Times Cited: 31
The Orexin receptors: Structural and anti-tumoral properties
Alain Couvineau, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysis
Mengzhen Zhou, Jiyou Tang, Shasha Li, et al.
Frontiers in Human Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review
Keisuke Suzuki
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 3, pp. 971-992
Open Access | Times Cited: 26
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies
Harry Fagan, Edward G. Jones, David S. Baldwin
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 1-12
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top